What is the prevalence of contraindications to Paxlovid among hospitalized COVID-19 patients?

AI background business technology, digital transformation

Researchers examined the prevalence of contraindications to nirmatrelvir-ritonavir (Paxlovid) in hospitalized coronavirus disease 2019 (COVID-19) patients.

COVID-19 fears led to anxiety in pregnant women

Previous article

The World’s Roots Are Getting Shallower

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News